
Rivastar 2.5mg Tablet
Marketer
Orris Pharmaceuticals
Salt Composition
Rivaroxaban (2.5mg)
Overview Rivastar 2.5mg Tablet
CardioGuard 2.5mg tablets function as an anticoagulant, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent thrombosis, it also mitigates clot risk post-knee or hip replacement. Administration is independent of meals; consistent daily dosing maximizes efficacy. Long-term, even lifelong, use may be necessary; discontinuing or altering dosage without physician consultation significantly increases the risk of stroke, heart attack, or thrombosis. Lifestyle modifications, including smoking cessation, healthy eating, regular exercise, and weight management, further reduce clot risk. Increased bleeding (nosebleeds, bruising) is a common side effect; report any adverse reactions promptly. Contraindicated in individuals with severe hepatic or renal impairment, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not recommended during treatment. Unlike some similar medications, routine PT-INR monitoring isn't required.
Primary Ingredients of Rivastar 2.5mg Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Rivastar 2.5mg Tablet
Preventing and managing blood clots.
Major Benefits of Rivastar 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. The tablet should be swallowed whole; avoid chewing, crushing, or fracturing it. Rivastar 2.5mg Tablets can be consumed with or without food, however, consistent timing is recommended for optimal results.
Common Side effects of Rivastar 2.5mg Tablet:
- Bleeding
How to use Rivastar 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rivastar 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Rivastar 2.5mg Tablet works:
Xarelto 2.5mg tablets represent a new class of oral blood thinners. Their mechanism of action involves inhibiting factor Xa, a key component in blood coagulation, thus reducing the risk of dangerous clot formation.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Rivastar 2.5mg Tablets requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Rivastar 2.5mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Rivastar 2.5mg tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Rivastar 2.5mg Tablets, which can induce dizziness or loss of consciousness. The use of Rivastar 2.5mg Tablets may result in side effects that compromise driving safety.
KidneyCAUTION
Patients with impaired kidney function should use Rivastar 2.5mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Rivastar 2.5mg tablets are contraindicated in individuals with severely compromised renal function.
LiverUNSAFE
Patients with liver impairment should likely refrain from using Rivastar 2.5mg tablets due to potential safety concerns. Medical advice is recommended.
What if you forget to take Rivastar 2.5mg Tablet :
Should you forget to take your Rivastar 2.5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rivastar 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Morpholine and thiophene derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | Xa Inhibitors for Oral Administration |
